DIRECTOR DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013GlobeNewsWire • 01/27/21
Osmotica Pharmaceuticals plc Receives Complete Response Letter from U.S. Food and Drug Administration for Arbaclofen Extended Release TabletsGlobeNewsWire • 12/29/20
Osmotica Pharmaceuticals plc Announces Agreement to Settle Patent Litigation with AdamasGlobeNewsWire • 12/02/20
RVL Pharmaceuticals, Inc. Strengthens Leadership Team as Commercial Launch of Upneeq® ExpandsGlobeNewsWire • 11/18/20
Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/12/20
Osmotica Pharmaceuticals' (OSMT) CEO Brian Markison on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business UpdatesGlobeNewsWire • 11/10/20
Osmotica Pharmaceuticals plc to Provide Third Quarter 2020 Business and Financial Update on November 10, 2020GlobeNewsWire • 11/05/20
JAMA Ophthalmology Publishes Pooled Analysis of Data from two Phase 3 Clinical Trials of Upneeq™ (oxymetazoline hydrochloride, 0.1% solution) for Acquired PtosisGlobeNewsWire • 10/01/20
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business UpdatesGlobeNewsWire • 08/11/20
Osmotica Pharmaceuticals plc to Provide Second Quarter 2020 Business and Financial Update and Presentation on Upneeq™ on August 11, 2020GlobeNewsWire • 08/07/20
OSMOTICA PHARM (OSMT) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 08/06/20
Santen and RVL Pharmaceuticals, Inc., an Osmotica Company, Enter into an Exclusive License Agreement in Japan, Asia, and EMEA for RVL-1201, a First-in-Class Treatment for Acquired BlepharoptosisGlobeNewsWire • 07/28/20
Osmotica Pharmaceutical US LLC Announces FDA User Fee Goal Date of December 29, 2020 for Arbaclofen Extended Release TabletsGlobeNewsWire • 07/20/20